Death toll rises to 45 in Sigachi Industries explosion in Hyderabad
The deceased was identified as 45-year-old Tarak from West Bengal, who suffered over 75% burn injuries in the June 30 explosion that ripped through the dryer unit of the firm located in Pashamylaram of Sangareddy district. Arrangements were made by district authorities to send the deceased's body to his native place. Currently, four more patients are undergoing treatment at the same hospital, with one of them, Rajesh Kumar Chowdary (42) from Bihar, being on a non-invasive ventilator (HIV).
The condition of the other three is stable, according to doctors.
Meanwhile, another two victims, Videshi Kahar (48) and Ganga Mukhiya (38), both of whom suffered from 40% burns, were declared stable and were discharged from another private hospital in Patancheru on Monday. Eight people are still untraced from the incident.
You Can Also Check:
Hyderabad AQI
|
Weather in Hyderabad
|
Bank Holidays in Hyderabad
|
Public Holidays in Hyderabad
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hindustan Times
3 hours ago
- Hindustan Times
How AI, biosensing and economic modelling are shaping globally scalable health care solutions
In the digital age, health innovation is no longer confined to the sterile boundaries of laboratories or the corridors of hospitals. A quiet revolution is underway—one that brings together the precision of artificial intelligence, the responsiveness of biosensing technology, and the foresight of economic analytics. This powerful convergence is not only redefining diagnostics but is also making health care smarter, faster, and more globally adaptable. AI(Getty Images/iStockphoto) At the heart of this transformation is a multidisciplinary approach that dissolves traditional silos between technology, medicine, and economics. By integrating wearable biosensors with edge AI and predictive modelling, emerging platforms like Lakshmi Kalyani Chinthala's HIVSense-Econ are not just detecting diseases—they are mapping out their ripple effects on human productivity, public resources, and long-term economic health. The foundation of this innovation lies in biosensing—a technology that captures physiological data directly from the human body. Miniaturised, non-invasive sensors can now track vital signs, immune responses, and even specific biomarkers for diseases like HIV. However, it's not the sensors alone that make the difference; it's what happens next. Edge AI processing—artificial intelligence deployed at or near the data source—analyses incoming signals in real time. This eliminates delays associated with cloud-based systems and enables on-the-spot interpretation. Combined, these technologies give health care providers the ability to detect illnesses not just early, but immediately, allowing for more precise intervention. What makes Chinthala's model uniquely powerful is its embrace of predictive economics. Health care has often been reactive—focused on treatment after the fact. But what if we could project the economic cost of an outbreak before it happens? What if decision-makers could calculate how a surge in illness might affect workforce productivity, insurance premiums, or public welfare budgets? By embedding economic algorithms into diagnostic platforms, predictive tools can now forecast potential financial losses tied to health trends. This is particularly vital for governments managing strained public health resources, for companies aiming to ensure workforce stability, and for NGOs responding to vulnerable communities. This economic layer also promotes preventative investment. If a system like HIVSense-Econ warns of a likely spike in HIV infections in a particular region, targeted resources can be deployed in advance. This saves not only lives, but funds—redirecting money from expensive crisis response towards sustainable prevention. Perhaps the most compelling aspect of this technological integration is its versatility across different environments. In high-income nations, such platforms can plug into enterprise health systems or insurance analytics. In lower-income or resource-constrained settings, the same system can operate through low-power devices, bringing cutting-edge predictive health care to the last mile. This kind of scalability is rare. Too often, health care technologies are designed with a single demographic or geographic context in mind. By contrast, tools that are adaptable—technically lightweight, cost-efficient, and intuitively designed—are the ones most likely to bridge global disparities in health care access. The convergence of biosensing, AI, and economic forecasting marks a shift towards more human-centred and sustainable health systems. It empowers policymakers with data, equips clinicians with real-time insights, and gives communities the foresight to act before problems become emergencies. As innovators like Chinthala continue to expand the reach of such platforms, the line between health diagnostics and economic planning will become increasingly blurred—for the better. We are witnessing not just an upgrade in medical technology, but a reimagination of public health itself: one that is predictive, participatory, and profoundly global. This article is authored by Dr. Olga, managing director, Ambisphere Research Laboratory.
Mint
16 hours ago
- Mint
Centre plans easier HIV care at patients' doorsteps, digital data management and patient tracing on the cards
New Delhi: The government plans to take HIV treatment and support to the doorsteps of over 2.5 million living with the virus. The Union health ministry is working on a "person-centered approach" instead of a uniform plan for everyone. This major overhaul, incorporated in the "Operational Guidelines for Care and Support Centres" by the National AIDS Control Organisation (NACO), aims to eradicate AIDS as a public health threat by 2030. According to the 'India HIV Estimation 2023' report, an estimated 2.54 million people were living with HIV in India. The report said that in 2023, approximately 35,870 people in India died due to causes related to AIDS. To be sure, not everyone with HIV develops AIDS, and anti- retroviral or ARV drugs have made living with the disease as manageable as any other condition. Furthermore, the government is looking to roll out new mobile applications such as the NACO-CSC app for tracking and monitoring HIV patients. This initiative aims to digitize data and improve efficiency. A significant change in this new strategy is the widespread adoption of community-based link ART centres (LACs), which will enable HIV patients to pick up their vital antiretroviral (ARV) medicines at local care and support centres, rather than having to travel long distances to bigger hospitals. This "decentralized approach" aims to make treatment much easier to access, especially for those facing travel difficulties, financial strain or other personal challenges. Beyond easier ARV access, the government is also leveraging a major technological leap: digital record-keeping and patient tracking through a new "NACO-CSC mobile application". This initiative will replace the older, time-consuming paper-based system, allowing for real-time updates and seamless coordination between HIV testing centres (ICTC), treatment centres (ARTCs), and the care and support centres (CSCs). This digital shift is expected to save time, speed up patient care, and make the entire process more transparent and efficient. Importantly, patient confidentiality will be strictly maintained as per government data policies. The new treatment guidelines prioritize crucial areas like the Elimination of Vertical Transmission of HIV & Syphilis (EVTHS). This is a vital step to prevent HIV and syphilis from being passed from mothers to their children during pregnancy, childbirth or breastfeeding. This focus is particularly urgent given that an estimated 2,350 new pediatric HIV infections in India in 2023 were due to such vertical transmission. The aim is to ensure that 95% of pregnant and breastfeeding women living with HIV achieve a suppressed viral load, a key factor in preventing transmission to their babies. 'Care and Support Centres (CSCs) will play a crucial role in this by proactively following up with pregnant women living with HIV to ensure they adhere to their treatment, get regular viral load tests, and that their babies receive necessary preventive medicines and early diagnosis," said an official aware of the matter. 'CSCs will help bridge the gaps in linking newly diagnosed individuals to treatment, improve how well patients stick to their medicine plans, and track those who might interrupt treatment or have a high viral load. CSCs also play a critical role in connecting patients to various social welfare schemes and actively work to reduce the stigma and discrimination that people living with HIV often face," the official added. Another focus of the new protocol is the comprehensive management of HIV-related co-morbidities and advanced HIV disease. This means addressing other health conditions that people living with HIV might develop, ensuring they receive holistic care. Indian pharmaceutical companies, including Cipla, Aurobindo Pharma, Zydus Lifesciences and Lupin, are key manufacturers of ARV drugs essential for HIV treatment. The market for HIV drugs is substantial, estimated at $250.23 million in 2022, with projections to grow to $389.90 million by 2030. Queries sent to the above mentioned companies remained unanswered. Raman Gangakhedkar, distinguished professor, Symbiosis International University, Pune and former C.G. Pandit national chair at the Indian Council on Medical Research (ICMR),said that though the National AIDS Control Programme continues to be one of the most successful nationally and internationally, it faces the challenge of linking 95% of HIV infected Individuals to ART services and ensure lifelong treatment adherence for the 2030 elimination goal. 'Vast number of People Living with HIV (PLHIV) cannot be followed up for the treatment and get missed, migration, opt out for treatment from closest clinics and social stigma are some of the key challenges for linkage as well continuation of antiretroviral therapy that has ensured that one can live as long as others who are not infected. Tracking individuals detected to be infected from detection to maintenance of suppressed viral load is critical," Dr. Gangakhedkar said. He said that to combat this, community involvement is paramount in the fight to eliminate HIV. 'The government now plans to establish more Care and Support Centres across the country in most of the districts and will not only track the person to ensure quality treatment against HIV disease but also monitor TB and other non-communicable diseases as a component of comprehensive care. The current guidelines cover objective parameters to be an agency to implement CSC related services, parameters used for rigorous monitoring and evaluation based on their performance. The HIV infected individuals will soon be able to get their medicines and refills directly from these local CSCs, eliminating the need to travel long distances to ART centres and when they are unable to travel due to sickness. The CSC will also counsel them comprehensively and also ensure measures related social stigma are handled well." He said that some of the patients on ART may prefer private healthcare to begin with and also during treatment from ART Centres. In such circumstances, the government often lacks crucial data on whether they're actually receiving treatment. 'To address this, all newly diagnosed HIV-positive individuals will now be linked to an ART centre. Furthermore, a digital mobile application will be instrumental in tracing patients anywhere in the country. Our major goal is to monitor active HIV cases and their treatment in India," said Dr. Gangakhedkar.
NDTV
a day ago
- NDTV
Mother-To-Child HIV Transmission Declined By 84% From 2010-2024: Minister
New Delhi: The number of vertical (mother-to-child) transmission of HIV has declined by around 84 per cent said Anupriya Patel, Union Minister of State for Health and Family Welfare, in the Parliament during the ongoing Monsoon Session. In a written reply to the Rajya Sabha, Ms Patel shared several steps taken by the government to enhance HIV/AIDS awareness. "Vertical transmission rate has also declined by around 74.5 per cent between 2010 and 2024 compared to around 56.5 per cent globally in the same reference period," Ms Patel said. Ms Patel noted that National Aids Control Organisation (NACO), a division of the Ministry of Health and Family Welfare, undertakes the responsibility to strengthen the awareness campaign against HIV/AIDs, through comprehensive multimedia campaigns, such as with information kiosks, and folk performances, among others. Digital platforms and social media are also actively leveraged to ensure broader engagement and awareness generation, especially among younger and tech-savvy audiences. Further, NACO rolled out 1,619 projects nationwide to support high-risk HIV populations. "High-risk groups, including female sex workers (FSW), men having sex with Men (MSM), people who inject drugs (PWID), hijra/transgender (TG) individuals, truck drivers, and migrants are specifically addressed through 1,619 targeted intervention projects across the country," Ms Patel said. Self-help groups, anganwadi workers, ASHAs, and members of Panchayati Raj institutions provide training and sensitisation programmes at the grassroots level, fostering community-level awareness and behavioural change.
